JSJesse R. Schank

Jesse R. Schank

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jesse R. Schank has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • Markus Heilig

    Center for Social and Affective Neuroscience, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden

    2 shared publications
  • Andrea L. Goldstein

    Laboratory of Clinical and Translational Studies, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD, USA

    1 shared publication
  • Annika Thorsell

    Laboratory of Clinical and Translational Studies, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, USA

    1 shared publication
  • Courtney E King

    Laboratory of Clinical and Translational Studies, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA

    1 shared publication
  • Courtney E. King

    Laboratory of Clinical and Translational Studies, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD, USA

    1 shared publication
  • David Weinshenker

    Department of Human Genetics, Emory University, Atlanta, GA, USA

    1 shared publication

Latest Publications

  • The Role of the Neurokinin-1 Receptor in Stress-Induced Reinstatement of Alcohol and Cocaine Seeking

    by Jesse R Schank, Courtney E King, Hui Sun, Kejun Cheng, Kenner C Rice, Markus Heilig, David Weinshenker, Jason P Schroeder

    Neurokinin-1 receptors (NK1Rs) have been shown to mediate alcohol and opiate, but not cocaine reward in rodents. We recently reported that NK1R antagonism also blocks stress-induced reinstatement of alcohol seeking in rats, but it is presently unknown whether these antirelapse properties extend to other drug classes. Although some work has suggested that intracranial substance P (SP) infusion reinstates cocaine seeking following extinction, no studies have indicated a direct role for the NK1R in reinstatement of cocaine seeking. Here, we explored the effect of the NK1R antagonist L822429 on yohimbine-induced reinstatement of alcohol or cocaine seeking in Long–Evans rats. Consistent with our previous findings with footshock-induced reinstatement of alcohol seeking in Wistar rats, we found that L822429 attenuates yohimbine-induced reinstatement of alcohol seeking, but does not affect baseline alcohol self-administration. We observed a similar suppression of yohimbine-induced reinstatement of cocaine seeking by L822429, and found that Long–Evans rats exhibit greater sensitivity to NK1R antagonism than Wistar rats. Accordingly, Long–Evans rats exhibit differences in the expression of NK1Rs in some subcortical brain regions. Combined, our findings suggest that while NK1R antagonism differentially influences alcohol- and cocaine-related behavior, this receptor mediates stress-induced seeking of both drugs.


  • The kappa opioid receptor antagonist JDTic attenuates alcohol seeking and withdrawal anxiety

    by Jesse R. Schank, Andrea L. Goldstein, Kelly E. Rowe, Courtney E. King, Julie A. Marusich, Jenny L. Wiley, F. Ivy Carroll, Annika Thorsell, Markus Heilig

    The role of kappa‐opioid receptors (KOR) in the regulation of alcohol‐related behaviors is not completely understood. For example, alcohol consumption has been reported to increase following treatment with KOR antagonists in rats, but was decreased in mice with genetic deletion of KOR. Recent studies have further suggested that KOR antagonists may selectively decrease alcohol self‐administration in rats following a history of dependence. We assessed the effects of the KOR antagonist JDTic on alcohol self‐administration, reinstatement of alcohol seeking induced by alcohol‐associated cues or stress, and acute alcohol withdrawal‐induced anxiety (‘hangover anxiety’). JDTic dose‐dependently reversed hangover anxiety when given 48 hours prior to testing, a time interval corresponding to the previously demonstrated anxiolytic efficacy of this drug. In contrast, JDTic decreased alcohol self‐administration and cue‐induced reinstatement of alcohol seeking when administered 2 hours prior to testing, but not at longer pre‐treatment times. For comparison, we determined that the prototypical KOR antagonist nor‐binaltorphimine can suppress self‐administration of alcohol at 2 hours pre‐treatment time, mimicking our observations with JDTic. The effects of JDTic were behaviorally specific, as it had no effect on stress‐induced reinstatement of alcohol seeking, self‐administration of sucrose, or locomotor activity. Further, we demonstrate that at a 2 hours pre‐treatment time JDTic antagonized the antinociceptive effects of the KOR agonist U50,488H but had no effect on morphine‐induced behaviors. Our results provide additional evidence for the involvement of KOR in regulation of alcohol‐related behaviors and provide support for KOR antagonists, including JDTic, to be evaluated as medications for alcoholism.